Is a microneedle patch containing combined oral contraceptive pills (OCPs), such as ethinyl estradiol and levonorgestrel, a suitable option for a female patient of reproductive age with no significant medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Micronele a Combined Oral Contraceptive?

No, "Micronele" does not appear to be a recognized combined oral contraceptive product name in the available medical literature or FDA-approved drug labels. You may be referring to a different contraceptive product, or there may be confusion about the product name.

Understanding Combined Oral Contraceptives

Combined oral contraceptives (COCs) contain both an estrogen component (typically ethinyl estradiol) and a progestin component delivered in pill form 1. These are distinct from:

  • Transdermal contraceptive patches (such as Ortho Evra), which deliver hormones through the skin and contain norelgestromin and ethinyl estradiol 1, 2
  • Vaginal rings, which are inserted vaginally and remain in place for 3 weeks 1
  • Progestin-only pills (mini-pills), which contain only progestin without estrogen 1

Common Combined Oral Contraceptive Formulations

If you are seeking information about combined oral contraceptives, typical formulations include:

  • Low-dose COCs containing ≤35 μg ethinyl estradiol with various progestins 1
  • Extended-cycle formulations such as levonorgestrel 100 μg/ethinyl estradiol 20 μg 3
  • Newer formulations containing 17β-estradiol with nomegestrol acetate 4

Recommendation for Clarification

Please verify the exact product name you are inquiring about. If you are asking about:

  • A combined oral contraceptive pill, these are highly effective with typical use failure rates of approximately 5% and perfect use failure rates of 0.1% 5
  • A contraceptive patch, this is also a combined hormonal method but delivered transdermally, not orally 1, 6

Key Contraindications to Screen For (If Prescribing Any Combined Hormonal Method)

Before prescribing any combined hormonal contraceptive, screen for absolute contraindications 6, 5:

  • History of venous thromboembolism or pulmonary embolism 6, 5
  • History of stroke or myocardial infarction 6, 5
  • Smoking in women ≥35 years of age 6
  • Uncontrolled hypertension (systolic ≥160 or diastolic ≥100 mmHg) 6
  • Current or history of breast cancer 6, 5
  • Active liver disease or hepatic tumors 6, 5
  • Pregnancy 6, 5
  • Undiagnosed abnormal vaginal bleeding 6, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.